Metastatic Breast Cancer
Conference Coverage
ctDNA spots breast cancer recurrence
Personalized surveillance technique has the potential to augment adjuvant therapy and improve long-term outcomes.
News
Neoadjuvant denosumab ineffective in breast cancer
Trial returns a negative result for the RANKL inhibitor, but identifies favored schedule for nab-paclitaxel.
News
‘Unlimited’ cancer costs: The Medicare Part D dilemma
Many patients with cancer who rely on Medicare Part D face an impossible choice: “Your money or your life.”
News
Sex hormones linked to breast cancer in men
Finding could point to a role for sex hormones, but more work needs to be done.
Conference Coverage
Quadruple-negative breast cancer associated with poorest outcomes
Patients lacking PD-L1 expression responded less to chemotherapy and had poor prognoses.
News
Mastectomy may not be necessary for young breast cancer patients
Treatment with mastectomy versus lumpectomy had no impact on survival, shows study.
Conference Coverage
Twenty years and counting: Tamoxifen’s lasting improvement in breast cancer
Study suggests long-term improvement for some women with breast cancer.
Conference Coverage
Uninformed breast cancer patients are making treatment decisions
Clouded by the thought “I have breast cancer,” patients are making uninformed treatment decisions.
News
Breast cancer test recommended for extended endocrine therapy
The benefit of endocrine therapy after 5 years in early-stage, HR-positive breast cancer is questionable, but the Breast Cancer Index can help...
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.